ADNT
Adient plc
ADNT has a slight edge over RIVN overall, supported by lower modeled downside and stronger fundamentals.
RIVN
Rivian Automotive, Inc.
RIVN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ADNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Stable |
ADNT's revenue, profitability, cash flow and balance sheet are all currently stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ADNT PE Valuation
ADNT has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
ADNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect ADNT's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over ADNT on the outlook, with more favorable revenue and profitability expectations.
ADNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.69 | — |
| Q3 2026 | -$0.24 | +$3.15 |
ADNT has the edge over RIVN in the latest year-over-year earnings comparison.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
ADNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +1.1% |
| Q2 2026 | $3.9B | +5% |
| Q1 2026 | $3.9B | +7% |
| Q4 2025 | $3.6B | +4.3% |
ADNT's revenue has grown year over year every quarter since late 2025: $3.7B last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 1.6% | -0.1 points |
| Q1 2026 | 2% | +9.3 points |
| Q4 2025 | 1.1% | -0.2 points |
| Q3 2025 | 1.7% | N/A |
| Q2 2025 | 1.8% | N/A |
| Q1 2025 | -7.3% | N/A |
| Q4 2024 | 1.3% | N/A |
ADNT has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
ADNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $138M | +20% |
| Q1 2026 | $8M | +$98M |
| Q4 2025 | $15M | -67% |
ADNT and RIVN do not have enough comparable growth data to identify a winner.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
ADNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -100K shares |
| 1 year | -5.4% | -4.5M shares |
ADNT has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $30M |
| Q1 2026 | — |
| Q4 2025 | $25M |
| Q3 2025 | $50M |
| Q2 2025 | $50M |
| Q1 2025 | — |
| Q4 2024 | $25M |
ADNT spent $105M buying back its own shares over the past year.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ADNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 6.7x | High |
| Q3 2025 | 6.1x | High |
| Q2 2025 | 6.5x | High |
| Q1 2025 | 7.6x | High |
| Q4 2024 | 3.5x | Elevated |
ADNT's net debt is about 2.5 years of its operating earnings (EBITDA), down from 6.5 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ADNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.6 | Neutral |
| Stochastic | 8.3 | Oversold |
ADNT's weekly RSI is 35 (neutral) and its Stochastic is 8 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
ADNT PE vs Consumer Cyclical Sector
| Metric | ADNT | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 18x | 68% above |
| PE % | 59 | 47 | 12 pts above |
ADNT has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
ADNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 6.8% below |
| 20 week MA | $18.6 | 15% below |
| 50 week MA | $20.3 | 22% below |
| 100 week MA | $19.5 | 19% below |
| 200 week MA | $25.9 | 39% below |
ADNT is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
ADNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.3 | $34.6 | +63% |
| 2021 | $34.6 | $46.9 | +36% |
| 2022 | $46.9 | $34.1 | -27% |
| 2023 | $34.1 | $36.4 | +6.8% |
| 2024 | $36.4 | $17.4 | -52% |
| 2025 | $17.4 | $19.5 | +12% |
| 2026 YTD | $19.5 | $15.8 | -19% |
ADNT has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.